ArticleGenome medicine2026
Aligned cross-modal integration and regulatory heterogeneity characterization of single-cell multiomic data with deep contrastive learning.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Towards Structural Restoration: Epigenetic Reprogramming and Direct Astrocyte-to-Neuron Lineage Conversion as Next-Generation Regenerative Neurotherapeutics.Molecular neurobiology · 2026Review
- Single-Cell Omics Advances in Understanding Tissue Development and Complex Trait Formation in Sheep and Goats.Animals : an open access journal from MDPI · 2026Review
- Aligned cross-modal integration and regulatory heterogeneity characterization of single-cell multiomic data with deep contrastive learning.Genome medicine · 2026Article
- Beyond cardiac fibroblasts: research advances on understanding and targeting intercellular communication networks in cardiac fibrosis.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSingle-cell multi-omics (scMulti-omics) technologies have revolutionized our understanding of cellular functions and interactions by enabling the simultaneous measurement of diverse cellular modalities. Integrating these heterogeneous data types presents significant challenges due to differences in scale, resolution, and biological variability across the omics layers. Traditional computational methods often fail to reconcile these differences, leading to a loss of critical biological variability and subtle intermolecular interactions.
methodsTo address these challenges, we have developed a single-cell multi-omics deep learning model (scMDCF) based on contrastive learning, tailored for the efficient characterization and integration of scMulti-omics data. scMDCF features a cross-modality contrastive learning module that harmonizes data representations across different omics types, ensuring consistency and preserving data heterogeneity by accommodating information entropy. Furthermore, a cross-modality feature fusion module extracts common low-dimensional latent representations of scMulti-omics data, effectively balancing the diverse characteristics of these data types.
resultsExtensive empirical studies demonstrate that scMDCF outperforms existing state-of-the-art scMulti-omics models across various types of scMulti-omics data. In particular, scMDCF exhibits advanced analytical capabilities in extracting cell-type-specific peak-gene associations and cis-regulatory elements from SNARE-seq data, and in elucidating immune regulation from CITE-seq data. In a post-BNT162b2 mRNA SARS-CoV-2 vaccination dataset, scMDCF successfully annotates specific vaccine-induced B cell subpopulations, uncovering dynamic interactions and regulatory mechanisms within the immune system post-vaccination. Most importantly, using Alzheimer's disease-specific data, scMDCF identifies computational minority Microglia and Endothelial cell populations, revealing ELF1 as a putative candidate transcription factor biomarker in Microglia, which potentially influences GTPase activity and may suppresses Alzheimer's pathology.
conclusionsWe propose scMDCF, a contrastive learning based framework for single-cell multi-omics integration that harmonizes cross-modality representations while preserving biological heterogeneity. Applications across diverse scMulti-omics datasets demonstrate improved clustering performance, effective batch-effect mitigation, and mechanistic insights into underlying biological processes. Code and reproducible workflows are openly available.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.